3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
5
Phase 1
5
Phase 2
3
Phase NA
1
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Conditions
Multiple Myeloma
19
Solid Tumor
18
Breast Neoplasms
14
Sarcoma
13
Head and Neck Neoplasms
13
Colorectal Neoplasms
13
Neoplasms
12
Lymphoma, B-Cell
12
Squamous Cell Carcinoma of Head and Neck
11
Pancreatic Neoplasms
11
Leukemia, Myeloid, Acute
11
Stomach Neoplasms
10
Melanoma
10
Lymphoma
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
8
Prostatic Neoplasms
7
Leukemia
7
Burkitt Lymphoma
7
Advanced Solid Tumors
7
Ovarian Neoplasms
6
Hematologic Neoplasms
6
Glioblastoma
6
Recurrence
5
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Carcinoma, Hepatocellular
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Neoplasm Metastasis
4
Interventions
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
INDUSTRY
×
Hypoxia
×
Clear all
NCT00884520
2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1
Completed
16 enrolled